Merck & Co. Inc.
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
46.62%
Market Cap
259.68 Bil.
P/E Ratio
14.46
Dividend Yield
3.12 %
Earnings per Share
6.45 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 105.14 G | 0 Units |
| PRICE DETERMINATION TIME | 06/23/2026 / 09:56:29 PM | |
| DAILY VOLUME (UNITS) | 50 | |
| DAILY HIGH / LOW | 105.14 | 100.48 |
| PREV. DAY'S PRICE | 101.02 | (06/22) |
| CHANGE DAY BEFORE | +4.12 | 4.08 % |
| 52 WEEK HIGH / LOW | 107.04 (06/05) | 66.4 (09/26) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 8.42 | 4.48 | 6.45 | 6.23 | 0.13 |
| DIVIDENDS PER SHARE | 3.10 | 2.96 | 2.91 | 2.88 | 2.74 |
| DIVIDEND YIELD IN % | - | - | 3.12 % | 3.14 % | 2.72 % |
| DIVIDEND GROWTH IN % | - | - | 0.80 % | 5.35 % | 2.83 % |
| PRICE - EARNINGS RATIO | 11.79 | 22.15 | 14.46 | 14.77 | 760.78 |
| PRICE - BOOK RATIO | - | - | 4.95 | 5.43 | 7.34 |
| PRICE - SALES RATIO | - | - | 4.06 | 3.95 | 4.64 |
| PRICE - CASH FLOW RATIO | - | - | 16.02 | 11.77 | 21.35 |
Master Data
| WKN | A0YD8Q |
| ISIN | US58933Y1055 |
| SYMBOL | 6MK |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Merck & Co. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 2.47 Bil. |
| MARKET CAPITALISATION | 259.68 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 6.13 % | -4.17 % | 5.77 % | 14.28 % | 46.62 % | 0.32 % | 65.78 % | 16.18 % |
| HIGH | 105.14 | 107.04 | 107.04 | 107.04 | 107.04 | 124.60 | 124.60 | 107.04 |
| LOW | 97.24 | 97.24 | 92.88 | 88.60 | 66.40 | 66.00 | 60.39 | 88.90 |
Dividend
per share
Company profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Structured products for Merck & Co. Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.